The authors of this study proved that the progression of amyotrophic lateral sclerosis (ALS) leads to the activation of PPARγ in motor neurons, which contributes to the increase in the activity of lipid detoxifying enzymes, such as lipoprotein lipase and glutathione S-transferase α-2. The gene discussed is GSTA1; the disease is amyotrophic lateral sclerosis.